SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...
On May 14, 2026, Valion Bio reported its first-quarter 2026 results, marking its first full reporting period under the new corporate identity and post-divestiture of its legacy consumer bioelectronics ...
Every year, the countries of Europe and assorted other locales gather to display the best songwriting that their country has to offer. The competition has given us such icons as Céline Dion, ABBA, and ...
KT-621 parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late 2027, respectively WATERTOWN, Mass., (GLOBE NEWSWIRE) -- Kymera ...
It's not too early to start planning for Wi-Fi 8. New features include non-primary channel access, seamless mobility domain ...
Inspecting subwavelength defects in dense nanopatterns is hindered by weak signals and strong background noise. Researchers ...
First-in-human healthy volunteers trial showed SYX-5219 was safe and well toleratedSystemic immunomodulation of type 2 inflammation demonstrated ...
Hourly ENTSO-E data show the summer midday-to-evening gap in French nuclear output has grown nearly eightfold since 2019. The ...
Peer-reviewed publication highlights preclinical findings demonstrating weight loss, lipid normalization, and reduction ...
New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 ...
MarketBeat on MSN
Pelthos Therapeutics Q1 earnings call highlights
Pelthos Therapeutics (NYSEAMERICAN:PTHS) reported higher first-quarter revenue as prescriptions for its lead product, ZELSUVMI, continued to grow in the treatment's third full quarter since launch, ...
Researchers have identified a pathway that triggers an immune response in cells with defective DNA repair. In particular, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results